Drug Profile
Moxonidine
Alternative Names: BDF 5895; BE 5895; Cynt; Moxodin; Normoxin; PhysiotensLatest Information Update: 09 Dec 2021
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Developer Giulini
- Class Centrally-acting antihypertensives; Heart failure therapies; Imidazoles; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists; Imidazoline I1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension